drug discovery

Cancer R&D Company Joins the NC Research Campus

November 07, 2017

The NC Research Campus (NCRC) welcomes R&S Chemicals, a cancer research and development company, to its roster of companies leasing ready-to-use laboratories in the David H. Murdock Core Laboratory. Srisailas Muthialu, PhD, PMP, vice president of R&S Chemicals, is leading the company’s study of two molecules that demonstrate anti-cancer activity. With additional research that will […]

The Match Game

August 17, 2017

Read the original article by Lori Lesko from Drug Discovery News. KANNAPOLIS, N.C.—Mixing and matching or repurposing drugs developed for one disease to treat another is nothing new, but Dr. Xiaohe Yang, senior researcher and associate professor at North Carolina Central University (NCCU), may have come up with an ideal match. Yang has discovered that well-known […]

Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer

January 19, 2017

Yingdong Zhu, Fang Wang, Yantao Zhao, Pei Wang & Shengmin Sang. Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer. Scientific Reports 7 (2017). Author Affiliations Laboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, 500 […]

Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.

March 19, 2009

Barnes M R, Harland L, Foord S M, Hall M D, Dix I, Thomas S, Williams-Jones B I, Brouwer C R. (2009) Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery. Nat Rev Drug Discov. 8:701-708. Abstract Pharmaceutical research and development is facing substantial challenges that have prompted the industry to shift funding from early- […]